Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 101 for “"Clusterin"”.
-
Clusterin in the Brain
… entities that could be targeted in pAD. Clusterin (CLU), initially identified in 1983, is a multifaceted, nearly ubiquitously expressed homeostatic regulator that is postulated to exist as multiple protein isoforms including a glycosylated mature/secreted form (mCLU) and smaller …
-
Structure and activity of human clusterin.
Clusterin is a heterodimeric disulfide linked glycoprotein secreted by many epithelia in adult and developing tissues. Clusterin is also induced in response to diverse injury or cell death stimuli. The protein interacts with, and is suggested to have, a relatively non specific affinity for markedly …
-
Clusterin negatively regulates melanogenesis via the TGFβ receptor-Smad pathway
Clusterin has been known as a biomarker of aging and is highly induced in stressed and senescent cells. In this study, RNA sequencing analysis showed transcripts for clusterin were highly expressed in UV irradiated fibroblasts. A considerable increase of clusterin was detected in the culture …
-
Clusterin: A Regulator of Glial Biology and Alzheimer’s Disease Pathogenesis
… play significant roles in AD pathogenesis. Clusterin (CLU), also known as apolipoprotein J, is the third most prominent risk gene associated with late-onset AD (LOAD). The precise role of CLU in the brain and in LOAD pathogenesis remains unclear. Multiple pieces of evidence have pointed to …
-
Βιολογικός ρόλος της απολιποπρωτεΐνης J/Clusterin στη γήρανση και στην καρκινογένεση
Apolipoprotein J/Clusterin (CLU) is a highly conserved glycoprotein that has been implicated in many physiological intracellular and extracellular functions as well as in disturbance states including ageing and age-related diseases (i.e. cancer). Four main isoforms of the protein have been reported …
-
Transcriptome-based analysis of molecular pathways for clusterin functions in kidney cells
Background: Clusterin (CLU) is a chaperone-like protein. Our previous studies have demonstrated that CLU protects kidney from ischemia-reperfusion injury (IRI) and enhances renal repair after IRI; however, the molecular pathways for its functions in the kidney are not fully understood. This study …
-
Investigation of serum clusterin as a suitable biomarker for canine multicentric lymphoma
… such as substage, immunophenotype and grade. Clusterin (CLU), also known as apolipoprotein J, is a heterodimeric glycoprotein which is widely expressed (Trougakos et al., 2002, 2004) throughout the body. CLU is important in tumorigenesis, apoptosis, and immunoregulation (Trougakos et al., …
-
Evidence for a role of the molecular chaperone clusterin in systemic amyloidosis
… in this thesis have explored the involvement of clusterin (CLU), a plasma protein, in transthyretin (TTR) and immunoglobulin light chain (LC) forms of systemic amyloidosis. CLU, ubiquitous in biological fluids, is an extracellular chaperone that is related to heat shock proteins. We hypothesized …
-
Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells
… in ischemic kidneys are not fully understood. Clusterin (CLU) is a chaperone-like protein and its expression is associated with kidney resistance to IRI. This study investigated the role of CLU in the prosurvival autophagy in the kidney. Renal IRI was induced in mice by clamping renal pedicles …
-
The role of clusterin in the amyloid cascade in human IPSC-derived neurons
… progressing, including the role of the protein clusterin in mediating β-amyloid (Aβ) toxicity. Mutations in CLU and APOE, major genetic AD risk factors, are known to have important roles in Aβ processing. This thesis aims to characterise the molecular cascade initiated by Aβ previously …
-
Προπαρασκευαστικές Μελέτες για τη δημιουργία Διαγονιδιακών Ποντικών για την πρωτεΐνη Απολιποπρωτεΐνη J/ Clusterin
… βρίσκονται σε εξέλιξη. Η Apolipoprotein J/Clusterin αποτελεί φαρμακευτικό στόχο, αφού μετά τη χρήση αντινοηματικών νουκλεοτιδίων που ανέστειλαν τη παραγωγή της (κλινικές δοκιμές φάσης IΙ) διαπιστώθηκε η αύξηση της επιβίωσης των ατόμων που έπασχαν από καρκίνο του προστάτη. Έτσι, για πρώτη …
-
DNA methylation of the clusterin promoter: Associations with Alzheimer’s Disease risk and related phenotypes
… risk. The third most associated AD risk gene is Clusterin (CLU), is also involved in the cholesterol/lipid pathway. CLU has been implicated in both a protective and aggravating role in AD making it a compelling gene for further study. The identification of a fluid-based AD biomarker/s has become …
-
The use of iPSC-derived neurons to investigate the role of clusterin trafficking in Alzheimer’s disease
<p>Clusterin’s role in neurodegeneration and Alzheimer’s disease (AD) remains unclear. Clusterin (CLU) protein expression and trafficking are altered in response to stress; the treatment of rodent neurons with beta-amyloid (Aβ) increases intracellular retention and reduces secretion of clusterin …
-
Regulation of the Insulin-like Growth Factor 1-Secretory Clusterin Expression Axis in Genomic Instability and Cell Stress
Secretory clusterin (sCLU) is a pro-survival factor that is up-regulated in human tumors and after exposure to cell stress. Understanding the regulation of sCLU expression in cancer, and after exposure to therapeutic agents, could reveal new therapeutic targets for cancer treatment. A DNA damage …
-
An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors
… controlled delivery of both phosphorothioated clusterin antisense oligonucleotide (clusterin ASO) and paclitaxel or docetaxel to prostate tumors to maintain therapeutic concentrations of the agents at the target disease site was investigated in this work. The primary objectives were to develop …
Page 1 of 6